 | • レポートコード：QYR9ST04182 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ヒト免疫不全ウイルス（HIV）-1治療薬の世界市場について調査・分析し、ヒト免疫不全ウイルス（HIV）-1治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ヌクレオシド-アナログ逆転写酵素阻害剤（NRTI）、非ヌクレオシド逆転写酵素阻害剤（NNRTI）、侵入及び融合阻害剤、プロテアーゼ阻害剤（PI）、インテグラーゼ阻害剤、共受容体拮抗薬）、用途別（病院、診療所、実験室）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のヒト免疫不全ウイルス（HIV）-1治療薬市場動向 ・主要企業別マーケットシェア ・ヒト免疫不全ウイルス（HIV）-1治療薬の種類別市場規模2014-2019 （ヌクレオシド-アナログ逆転写酵素阻害剤（NRTI）、非ヌクレオシド逆転写酵素阻害剤（NNRTI）、侵入及び融合阻害剤、プロテアーゼ阻害剤（PI）、インテグラーゼ阻害剤、共受容体拮抗薬） ・ヒト免疫不全ウイルス（HIV）-1治療薬の用途別市場規模2014-2019 （病院、診療所、実験室） ・ヒト免疫不全ウイルス（HIV）-1治療薬の北米市場：主要企業・種類別/用途別市場規模 ・ヒト免疫不全ウイルス（HIV）-1治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ヒト免疫不全ウイルス（HIV）-1治療薬の中国市場：主要企業・種類別/用途別市場規模 ・ヒト免疫不全ウイルス（HIV）-1治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・ヒト免疫不全ウイルス（HIV）-1治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・ヒト免疫不全ウイルス（HIV）-1治療薬のインド市場：主要企業・種類別/用途別市場規模 ・ヒト免疫不全ウイルス（HIV）-1治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AbbVie, Inc.(U.S.)、Merck & Co., Inc. (U.S.)、Bristol-Myers Squibb Company (U.S.)、Boehringer Ingelheim GmbH (Germany)、Genentech, Inc. (U.S.)、Cipla, Inc. (India)） ・ヒト免疫不全ウイルス（HIV）-1治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.The key factors responsible for driving the market growth include the increasing incidence of HIV infections especially amongst the youth due to unprotected sexual practices, exposure to needles or syringes contaminated with infected body fluids or tissues, lack of awareness regarding transmission risk factors, etc.
In 2018, the global Human Immunodeficiency Virus (HIV)-1 Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Human Immunodeficiency Virus (HIV)-1 Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Immunodeficiency Virus (HIV)-1 Therapeutics development in United States, Europe and China.
The key players covered in this study
AbbVie, Inc.(U.S.)
Merck & Co., Inc. (U.S.)
Bristol-Myers Squibb Company (U.S.)
Boehringer Ingelheim GmbH (Germany)
Genentech, Inc. (U.S.)
Cipla, Inc. (India)
…
Market segment by Type, the product can be split into
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Market segment by Application, split into
Hospitals
Clinics
Labs
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Human Immunodeficiency Virus (HIV)-1 Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Human Immunodeficiency Virus (HIV)-1 Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Human Immunodeficiency Virus (HIV)-1 Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.4.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.4.4 Entry and Fusion Inhibitors
1.4.5 Protease Inhibitors (PIs)
1.4.6 Integrase Inhibitors
1.4.7 Coreceptor Antagonists
1.5 Market by Application
1.5.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Labs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size
2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Growth Trends by Regions
2.2.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions (2014-2025)
2.2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Manufacturers
3.1.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players Head office and Area Served
3.3 Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Product/Solution/Service
3.4 Date of Enter into Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-2019)
4.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2014-2019)
5.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in United States
5.3 United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
5.4 United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
6 Europe
6.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2014-2019)
6.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in Europe
6.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
6.4 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
7 China
7.1 China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2014-2019)
7.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in China
7.3 China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
7.4 China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
8 Japan
8.1 Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2014-2019)
8.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in Japan
8.3 Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
8.4 Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2014-2019)
9.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
9.4 Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
10 India
10.1 India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2014-2019)
10.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in India
10.3 India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
10.4 India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2014-2019)
11.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players in Central & South America
11.3 Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
11.4 Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
12 International Players Profiles
12.1 AbbVie, Inc.(U.S.)
12.1.1 AbbVie, Inc.(U.S.) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.1.4 AbbVie, Inc.(U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
12.1.5 AbbVie, Inc.(U.S.) Recent Development
12.2 Merck & Co., Inc. (U.S.)
12.2.1 Merck & Co., Inc. (U.S.) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.2.4 Merck & Co., Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
12.2.5 Merck & Co., Inc. (U.S.) Recent Development
12.3 Bristol-Myers Squibb Company (U.S.)
12.3.1 Bristol-Myers Squibb Company (U.S.) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Company (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Company (U.S.) Recent Development
12.4 Boehringer Ingelheim GmbH (Germany)
12.4.1 Boehringer Ingelheim GmbH (Germany) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.4.4 Boehringer Ingelheim GmbH (Germany) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
12.4.5 Boehringer Ingelheim GmbH (Germany) Recent Development
12.5 Genentech, Inc. (U.S.)
12.5.1 Genentech, Inc. (U.S.) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.5.4 Genentech, Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
12.5.5 Genentech, Inc. (U.S.) Recent Development
12.6 Cipla, Inc. (India)
12.6.1 Cipla, Inc. (India) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
12.6.4 Cipla, Inc. (India) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
12.6.5 Cipla, Inc. (India) Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Market Segments
Table Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Covered
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type 2014-2025
Figure Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Figures
Table Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Figure Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Figures
Table Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Figure Entry and Fusion Inhibitors Figures
Table Key Players of Entry and Fusion Inhibitors
Figure Protease Inhibitors (PIs) Figures
Table Key Players of Protease Inhibitors (PIs)
Figure Integrase Inhibitors Figures
Table Key Players of Integrase Inhibitors
Figure Coreceptor Antagonists Figures
Table Key Players of Coreceptor Antagonists
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Labs Case Studies
Figure Human Immunodeficiency Virus (HIV)-1 Therapeutics Report Years Considered
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions 2014-2019
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions 2014-2019
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Manufacturers in 2018
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Product/Solution/Service
Table Date of Enter into Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Type (2014-2019)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Application (2014-2019)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Application in 2018
Figure United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2018-2019)
Table United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2014-2019)
Table United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2014-2019)
Figure Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2018-2019)
Table Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2014-2019)
Table Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2014-2019)
Figure China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2018-2019)
Table China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2014-2019)
Table China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2014-2019)
Figure Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2018-2019)
Table Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2014-2019)
Table Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2018-2019)
Table Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2014-2019)
Figure India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2018-2019)
Table India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2014-2019)
Table India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share (2018-2019)
Table Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2014-2019)
Table Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2014-2019)
Table AbbVie, Inc.(U.S.) Company Details
Table AbbVie, Inc.(U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019) (Million US$)
Figure AbbVie, Inc.(U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
Table AbbVie, Inc.(U.S.) Recent Development
Table Merck & Co., Inc. (U.S.) Company Details
Table Merck & Co., Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)(Million US$)
Figure Merck & Co., Inc. (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
Table Merck & Co., Inc. (U.S.) Recent Development
Table Bristol-Myers Squibb Company (U.S.) Company Details
Table Bristol-Myers Squibb Company (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Company (U.S.) Recent Development
Table Boehringer Ingelheim GmbH (Germany) Company Details
Table Boehringer Ingelheim GmbH (Germany) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim GmbH (Germany) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
Table Boehringer Ingelheim GmbH (Germany) Recent Development
Table Genentech, Inc. (U.S.) Company Details
Table Genentech, Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)(Million US$)
Figure Genentech, Inc. (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
Table Genentech, Inc. (U.S.) Recent Development
Table Cipla, Inc. (India) Company Details
Table Cipla, Inc. (India) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)(Million US$)
Figure Cipla, Inc. (India) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2014-2019)
Table Cipla, Inc. (India) Recent Development
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Regions in 2025
Figure United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Product (2019-2025)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Product in 2025
Table Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2019-2025)
Figure Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
HIV治療薬の世界市場：市場規模・現状・予測 The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.HIV spreads through fluidic e…- HIV薬の世界市場：インサイト・予測 HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.One …
- TNF阻害剤の世界市場：市場規模・現状・予測 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- TNF阻害剤の世界市場：市場規模・現状・予測 TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- 免疫チェックポイント阻害剤の世界市場：市場規模・現状・予測 Check point inhibitors are molecules that use the cosmic potential of the immune response system of the body, and its limitless influences to attack the cancer cells present inside the body, as well as avoids relapse of cancer cells. In case any relapse occurs in the body, it can easily be recognize…